5 completed. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Clonazepam: new trials by email Literature Review of Clonazepam trials Research Report on Clonazepam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploring the Role of the GABAergic Modulation in Pain Transmission in Human NDMC 20mg, NDMC60mg, Clonazepam 1.5mg - Neuropathic Pain | Phase 1 | Completed | Jules Desmeules | 56 | 2017-03-30 | 2019-04-19 |
| GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation Clonazepam, Tolterodine, clobazam - Neuropathic Pain | Phase 1 / Phase 2 | Completed | University Hospital, Geneva | 25 | 2010-04-01 | 2011-12-14 |
| Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population Alprazolam, Alprazolam XR, Clonazepam - Pharmacokinetics | Phase 1 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 24 | 2008-10-01 | 2021-01-28 |
| Bioavailability Study of Clonazepam ODT Under Fasting Conditions Clonazepam, Klonopin Wafers - To Determine Bioequivalence Under Fasting Conditions | Phase 1 | Completed | Par Pharmaceutical, Inc. | 32 | 2004-03-01 | 2008-04-04 |
| Bioavailability Study of Clonazepam Tablets Under Fasting Conditions Clonazepam, Klonopin - To Determine Bioequivalence Under Fasting Conditions | Phase 1 | Completed | Par Pharmaceutical, Inc. | 32 | 2004-02-01 | 2008-04-04 |
Fasting (2) · Neuralgia (2) · Chronic Pain (1)
Par Pharmaceutical, Inc. (2) · Jules Desmeules (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · University Hospital, Geneva (1)
Switzerland (2) · Mexico (1)
Gary Shillito (2) · Ali Ziaee (1) · Irwin Plisco (1)